BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Sheikh A, Khired Z. Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity. Medicina (Kaunas) 2021;58:46. [PMID: 35056355 DOI: 10.3390/medicina58010046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Barth M, Häfner N, Runnebaum IB, Weigand W. Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines. IJMS 2023;24:5718. [DOI: 10.3390/ijms24065718] [Reference Citation Analysis]
2 Lae Lae Phoo N, Sukhamwang A, Dejkriengkraikul P, Yodkeeree S. Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways. IJMS 2022;23:12066. [DOI: 10.3390/ijms232012066] [Reference Citation Analysis]
3 Ismail NAS, Lee JX, Yusof F. Platinum Nanoparticles: The Potential Antioxidant in the Human Lung Cancer Cells. Antioxidants 2022;11:986. [DOI: 10.3390/antiox11050986] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Muttar A, Ahmed I, Hameed H. The optimum inhibitory effects of Alpha Interferon and Cisplatin in colon cancer, a comparative in vitro study. J Med Life 2022;15:269-77. [PMID: 35419098 DOI: 10.25122/jml-2021-0336] [Reference Citation Analysis]